这是一篇来自已证抗体库的有关小鼠 Mmp2的综述,是根据89篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Mmp2 抗体。
Mmp2 同义词: Clg4a; GelA; MMP-2

圣克鲁斯生物技术
小鼠 单克隆(8B4)
  • 免疫组化; 小鼠; 图 s3
  • 免疫印迹; 小鼠; 图 s3
圣克鲁斯生物技术 Mmp2抗体(Santa Cruza, 8B4)被用于被用于免疫组化在小鼠样本上 (图 s3) 和 被用于免疫印迹在小鼠样本上 (图 s3). Cell Commun Signal (2020) ncbi
小鼠 单克隆(2C1)
  • 免疫印迹; 人类; 1:500; 图 3l
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz Biotechnology, sc-13594)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 3l). elife (2020) ncbi
小鼠 单克隆(8B4)
  • 免疫组化-石蜡切片; 大鼠; 1:200; 图 1f, 2f
  • 免疫印迹; 大鼠; 1:200; 图 5c
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz Biotechnology, sc-13595)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:200 (图 1f, 2f) 和 被用于免疫印迹在大鼠样本上浓度为1:200 (图 5c). Int J Nanomedicine (2020) ncbi
小鼠 单克隆(2C1)
  • 免疫印迹; 人类; 1:1000; 图 1e
圣克鲁斯生物技术 Mmp2抗体(Santa, sc-13594)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1e). Aging (Albany NY) (2019) ncbi
小鼠 单克隆(2C1)
  • 免疫印迹; 人类; 1:500; 图 6d
圣克鲁斯生物技术 Mmp2抗体(Santa, sc-13594)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 6d). Aging (Albany NY) (2019) ncbi
小鼠 单克隆(8B4)
  • 免疫印迹; 小鼠; 图 3d
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz, sc-13595)被用于被用于免疫印迹在小鼠样本上 (图 3d). Front Immunol (2019) ncbi
小鼠 单克隆(8B4)
  • 免疫印迹; 人类; 图 5a
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz Biotechnology, sc-13595)被用于被用于免疫印迹在人类样本上 (图 5a). Exp Cell Res (2019) ncbi
小鼠 单克隆(2C1)
  • 免疫印迹; 大鼠; 1:500; 图 5a
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz Biotechnology, sc-13594)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 5a). Mol Med Rep (2017) ncbi
小鼠 单克隆(2C1)
  • 免疫印迹; 小鼠; 图 1f
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz, sc-13594)被用于被用于免疫印迹在小鼠样本上 (图 1f). Respir Res (2016) ncbi
小鼠 单克隆(8B4)
  • 免疫印迹; 小鼠; 图 7a
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz Biotechnology, Inc., sc13595)被用于被用于免疫印迹在小鼠样本上 (图 7a). J Exp Med (2016) ncbi
小鼠 单克隆(4D3)
  • 免疫组化-石蜡切片; pigs ; 1:50; 图 s15
圣克鲁斯生物技术 Mmp2抗体(santa Cruz, sc-53630)被用于被用于免疫组化-石蜡切片在pigs 样本上浓度为1:50 (图 s15). Arthritis Res Ther (2016) ncbi
小鼠 单克隆(8B4)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz, sc-13595)被用于被用于免疫印迹在人类样本上 (图 5). J Cancer (2016) ncbi
小鼠 单克隆(8B4)
  • 免疫印迹; 大鼠; 1:1000; 图 2
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz Biotechnology, sc-13595)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 2). Int J Med Sci (2016) ncbi
小鼠 单克隆(8B4)
  • 免疫印迹; 小鼠; 1:500; 图 3
  • 免疫印迹; 人类; 1:500; 图 3
圣克鲁斯生物技术 Mmp2抗体(santa Cruz, sc-13595)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 3) 和 被用于免疫印迹在人类样本上浓度为1:500 (图 3). BMC Cancer (2015) ncbi
小鼠 单克隆(8B4)
  • 免疫组化-石蜡切片; 大鼠; 1:100; 图 4A
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz, sc-13595)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:100 (图 4A). Diabetol Metab Syndr (2015) ncbi
小鼠 单克隆(2C1)
  • 免疫印迹; 人类; 1:500; 图 2b
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz, sc-13594)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2b). Mol Med Rep (2015) ncbi
小鼠 单克隆(2C1)
  • 免疫印迹; 大鼠; 1:500; 图 8
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz, SC13594)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 8). Int J Mol Med (2015) ncbi
小鼠 单克隆(8B4)
  • 免疫组化-石蜡切片; 人类; 图 5
  • 免疫印迹; 人类; 图 3c
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz, SC-13595)被用于被用于免疫组化-石蜡切片在人类样本上 (图 5) 和 被用于免疫印迹在人类样本上 (图 3c). Mol Med Rep (2015) ncbi
小鼠 单克隆(8B4)
  • 免疫印迹; 人类; 1:800; 图 4
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz, sc-13595)被用于被用于免疫印迹在人类样本上浓度为1:800 (图 4). Exp Ther Med (2015) ncbi
小鼠 单克隆(2C1)
  • 免疫印迹; 人类; 1:1000; 图 2
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz Biotechnology, sc-13594)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2). Mol Med Rep (2015) ncbi
小鼠 单克隆(8B4)
  • 免疫印迹; 人类; 1:1500
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz Biotech, sc-13595)被用于被用于免疫印迹在人类样本上浓度为1:1500. Biochem Biophys Res Commun (2015) ncbi
小鼠 单克隆(4D3)
  • 免疫组化-石蜡切片; 人类; 1:100
  • 免疫细胞化学; 人类; 1:200
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz, SC53630)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 和 被用于免疫细胞化学在人类样本上浓度为1:200. Cell Death Dis (2014) ncbi
小鼠 单克隆(2C1)
  • 免疫印迹; 人类; 1:1000; 图 4
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz Biotechnology, sc-13594)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Mol Med Rep (2014) ncbi
小鼠 单克隆(4D3)
  • 免疫印迹; 人类; 1:1000; 图 4
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz Biotechnology, sc-53630)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Oncol Rep (2014) ncbi
小鼠 单克隆(8B4)
  • 免疫组化-石蜡切片; 人类; 图 1
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz, 8B4)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1). PLoS ONE (2014) ncbi
小鼠 单克隆(2C1)
  • 免疫印迹; 人类; 图 4a
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz, 2C1)被用于被用于免疫印迹在人类样本上 (图 4a). Oncotarget (2014) ncbi
小鼠 单克隆(8B4)
  • 免疫组化-石蜡切片; 小鼠; 1:200
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz, sc-13595)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200. J Mol Cell Cardiol (2014) ncbi
小鼠 单克隆(2C1)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 Mmp2抗体(Santa Cruz Biotechnology, sc-13594)被用于被用于免疫印迹在人类样本上 (图 4). Mol Carcinog (2014) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 5e
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5e). Acta Neuropathol Commun (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 6b
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 6b). BMC Cancer (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 s1c
  • 免疫印迹; 小鼠; 1:1000; 图 2k
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 s1c) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2k). EBioMedicine (2020) ncbi
domestic rabbit 单克隆(EPR1184)
  • 免疫印迹; 人类; 1:1000; 图 1f, 5a
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, Cambridge, England, ab92536)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1f, 5a). Integr Cancer Ther (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 7e
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫印迹在人类样本上 (图 7e). Aging (Albany NY) (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 2k
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2k). Front Oncol (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2c
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫印迹在人类样本上 (图 2c). Braz J Med Biol Res (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 5e
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5e). Aging (Albany NY) (2019) ncbi
domestic rabbit 单克隆(EPR1184)
  • 免疫印迹; 大鼠; 1:1000; 图 2c
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab92536)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 2c). Biomed Res Int (2019) ncbi
domestic rabbit 单克隆(EPR1184)
  • 免疫组化-石蜡切片; 小鼠; 图 7a
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab92536)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 7a). Front Immunol (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:800; 图 7a
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:800 (图 7a). Oncotarget (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:500; 图 1a
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 1a). Biomed Pharmacother (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 6c
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 6c). Biosci Rep (2018) ncbi
domestic rabbit 多克隆
  • 免疫组化; 大鼠; 图 1a
  • 免疫印迹; 大鼠; 图 1b
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫组化在大鼠样本上 (图 1a) 和 被用于免疫印迹在大鼠样本上 (图 1b). J Neurosci (2018) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:200; 图 s3b
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, Ab 37150)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 s3b). Oncotarget (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100; 图 9d
  • 免疫印迹; 人类; 1:1000; 图 2e
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 9d) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2e). Oncotarget (2017) ncbi
domestic rabbit 单克隆(EPR1184)
  • 免疫印迹; 大鼠; 图 7
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab92536)被用于被用于免疫印迹在大鼠样本上 (图 7). PLoS ONE (2017) ncbi
domestic rabbit 单克隆(EPR1184)
  • 免疫印迹; 人类; 1:1000; 图 6B; 6D; 6F
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab92536)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6B; 6D; 6F). Onco Targets Ther (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 2e
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫印迹在小鼠样本上 (图 2e). Arterioscler Thromb Vasc Biol (2017) ncbi
domestic rabbit 单克隆(EPR1184)
  • 免疫印迹; 人类; 1:800; 图 5b
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab92536)被用于被用于免疫印迹在人类样本上浓度为1:800 (图 5b). Oncotarget (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:200; 图 6a
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 6a). Mol Cell Biol (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3a
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). Oncol Lett (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 10
艾博抗(上海)贸易有限公司 Mmp2抗体(abcam, ab37150)被用于被用于免疫印迹在人类样本上 (图 10). Eur Cell Mater (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:500; 图 5
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 5). Exp Ther Med (2016) ncbi
domestic rabbit 单克隆(EPR1184)
  • 免疫组化-冰冻切片; 小鼠; 图 7a
  • 免疫印迹; 小鼠; 图 4f
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab92536)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 7a) 和 被用于免疫印迹在小鼠样本上 (图 4f). Oncogene (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 5b
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5b). Oncotarget (2016) ncbi
小鼠 单克隆(6E3F8)
  • 免疫印迹; 人类; 1:1000; 图 7
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab86607)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7). J Cell Mol Med (2016) ncbi
小鼠 单克隆(6E3F8)
  • 免疫组化; 人类; 图 2
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab86607)被用于被用于免疫组化在人类样本上 (图 2). Int Braz J Urol (2015) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 1.25 ug/ml
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab37150)被用于被用于免疫组化在人类样本上浓度为1.25 ug/ml. Support Care Cancer (2016) ncbi
小鼠 单克隆(6E3F8)
  • 免疫印迹; 人类; 1:1000; 图 5
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab86607)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5). Cancer Sci (2015) ncbi
小鼠 单克隆(6E3F8)
  • 免疫组化; 小鼠; 1:200; 图 6
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab86607)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 6). J Cell Mol Med (2015) ncbi
小鼠 单克隆(6E3F8)
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab86607)被用于被用于免疫印迹在人类样本上. World J Gastroenterol (2014) ncbi
小鼠 单克隆(6E3F8)
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab86607)被用于被用于免疫印迹在人类样本上浓度为1:1000. Cancer Lett (2014) ncbi
小鼠 单克隆(6E3F8)
  • 免疫组化-石蜡切片; 人类; 1:150
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab86607)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:150. J Perinatol (2015) ncbi
domestic rabbit 单克隆(EPR1184)
  • 免疫印迹基因敲除验证; 小鼠; 图 3
  • 免疫细胞化学; 小鼠; 图 2
艾博抗(上海)贸易有限公司 Mmp2抗体(Abcam, ab92536)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 3) 和 被用于免疫细胞化学在小鼠样本上 (图 2). Am J Physiol Heart Circ Physiol (2014) ncbi
赛默飞世尔
小鼠 单克隆(CA-4001 or CA719E3C)
  • 免疫印迹; 小鼠; 图 4b
赛默飞世尔 Mmp2抗体(Thermo Fisher Scientific, MA5-13590)被用于被用于免疫印迹在小鼠样本上 (图 4b). Molecules (2019) ncbi
小鼠 单克隆(101)
  • 免疫组化-冰冻切片; 非洲爪蛙; 图 1
赛默飞世尔 Mmp2抗体(Invitrogen, 436000)被用于被用于免疫组化-冰冻切片在非洲爪蛙样本上 (图 1). PLoS ONE (2014) ncbi
小鼠 单克隆(CA-4001 or CA719E3C)
  • 免疫组化; 人类; 1:50
赛默飞世尔 Mmp2抗体(Lab Vision Corporation, CA-4001)被用于被用于免疫组化在人类样本上浓度为1:50. Histopathology (2015) ncbi
小鼠 单克隆(CA-4001 or CA719E3C)
  • 免疫印迹; 小鼠; 图 3a
赛默飞世尔 Mmp2抗体(Lab Vision, MS-567-P0)被用于被用于免疫印迹在小鼠样本上 (图 3a). Brain Res (2009) ncbi
小鼠 单克隆(101)
  • 免疫印迹; 小鼠; 图 1
赛默飞世尔 Mmp2抗体(Zymed, noca)被用于被用于免疫印迹在小鼠样本上 (图 1). Proc Natl Acad Sci U S A (2006) ncbi
Novus Biologicals
小鼠 单克隆(8B4)
  • 免疫组化-石蜡切片; 小鼠; 图 2a
Novus Biologicals Mmp2抗体(Novus Biologicals, NB200-114)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2a). Cell Metab (2019) ncbi
西格玛奥德里奇
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5
西格玛奥德里奇 Mmp2抗体(Sigma, M4065)被用于被用于免疫印迹在人类样本上 (图 5). PLoS ONE (2016) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 2g: 2h, 2i
赛信通(上海)生物试剂有限公司 Mmp2抗体(CST, 4022)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2g: 2h, 2i). Am J Cancer Res (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:2000; 图 3b
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling Technology, 4022)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 3b). Int J Mol Med (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2e
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling, 4022)被用于被用于免疫印迹在人类样本上 (图 2e). Cell Signal (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4c
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling, 4022)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4c). Mol Med Rep (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 4a
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling, 4022)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4a). Redox Biol (2019) ncbi
domestic rabbit 多克隆
  • 其他; 人类; 图 4c
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling, 4022)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:500; 图 3D
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling, 4022)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 3D). Oncol Lett (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 7b
赛信通(上海)生物试剂有限公司 Mmp2抗体(cell signalling, 4022)被用于被用于免疫印迹在人类样本上 (图 7b). Cell Death Dis (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5e
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling, 4022)被用于被用于免疫印迹在人类样本上 (图 5e). Br J Cancer (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3c
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling, 4022)被用于被用于免疫印迹在人类样本上 (图 3c). Biomed Pharmacother (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:800; 图 3c
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling, 4022)被用于被用于免疫印迹在人类样本上浓度为1:800 (图 3c). Oncol Lett (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s4a
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling Technology, 4022)被用于被用于免疫印迹在人类样本上 (图 s4a). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1
  • 免疫印迹; 小鼠; 图 5
赛信通(上海)生物试剂有限公司 Mmp2抗体(santa Cruz, 4022)被用于被用于免疫印迹在人类样本上 (图 1) 和 被用于免疫印迹在小鼠样本上 (图 5). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司 Mmp2抗体(cell signalling, 4022S)被用于被用于免疫印迹在人类样本上 (图 5a). Int J Mol Sci (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3c
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling, 4022)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). PLoS ONE (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 6a
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling Technology, 4022)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6a). J Clin Invest (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 8
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling Technology, 4022S)被用于被用于免疫印迹在小鼠样本上 (图 8) 和 被用于免疫印迹在人类样本上 (图 4). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling Technologies, 4022)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Oncol Lett (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 1
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling, 4022)被用于被用于免疫印迹在小鼠样本上 (图 1) 和 被用于免疫印迹在人类样本上 (图 5). J Biol Chem (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mmp2抗体(Cell Signaling, 4022)被用于被用于免疫印迹在人类样本上. Mol Carcinog (2016) ncbi
文章列表
  1. Wang B, Li Q, Wang J, Zhao S, Nashun B, Qin L, et al. Plasmodium infection inhibits tumor angiogenesis through effects on tumor-associated macrophages in a murine implanted hepatoma model. Cell Commun Signal. 2020;18:157 pubmed 出版商
  2. Pathak T, Gueguinou M, Walter V, Delierneux C, Johnson M, Zhang X, et al. Dichotomous role of the human mitochondrial Na+/Ca2+/Li+ exchanger NCLX in colorectal cancer growth and metastasis. elife. 2020;9: pubmed 出版商
  3. Lackie R, Marques Lopes J, Ostapchenko V, Good S, Choy W, van Oosten Hawle P, et al. Increased levels of Stress-inducible phosphoprotein-1 accelerates amyloid-β deposition in a mouse model of Alzheimer's disease. Acta Neuropathol Commun. 2020;8:143 pubmed 出版商
  4. Kang K, Lee S, Kim J, Lee B, Kim S, Park Y, et al. Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization. BMC Cancer. 2020;20:619 pubmed 出版商
  5. Song H, Xu T, Feng X, Lai Y, Yang Y, Zheng H, et al. Itaconate prevents abdominal aortic aneurysm formation through inhibiting inflammation via activation of Nrf2. EBioMedicine. 2020;57:102832 pubmed 出版商
  6. Chen Z, Zhang J, Xue H, Qian M, Guo X, Gao X, et al. Nitidine Chloride Is a Potential Alternative Therapy for Glioma Through Inducing Endoplasmic Reticulum Stress and Alleviating Epithelial-Mesenchymal Transition. Integr Cancer Ther. 2020;19:1534735419900927 pubmed 出版商
  7. Lin Y, Huang X, Chang K, Liao K, Tsai N. Encapsulated n-Butylidenephthalide Efficiently Crosses the Blood-Brain Barrier and Suppresses Growth of Glioblastoma. Int J Nanomedicine. 2020;15:749-760 pubmed 出版商
  8. Tian S, Peng P, Li J, Deng H, Zhan N, Zeng Z, et al. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway. Aging (Albany NY). 2020;12:3574-3593 pubmed 出版商
  9. Li M, Wu P, Yang Z, Deng S, Ni L, Zhang Y, et al. miR-193a-5p promotes pancreatic cancer cell metastasis through SRSF6-mediated alternative splicing of OGDHL and ECM1. Am J Cancer Res. 2020;10:38-59 pubmed
  10. Cai H, Li J, Zhang Y, Liao Y, Zhu Y, Wang C, et al. LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial-Mesenchymal Transition. Front Oncol. 2019;9:1446 pubmed 出版商
  11. Yang X, Jiang J, Zhang C, Li Y. Baicalein restrains proliferation, migration, and invasion of human malignant melanoma cells by down-regulating colon cancer associated transcript-1. Braz J Med Biol Res. 2019;52:e8934 pubmed 出版商
  12. Yang Y, Tang F, Wei F, Yang L, Kuang C, Zhang H, et al. Silencing of long non-coding RNA H19 downregulates CTCF to protect against atherosclerosis by upregulating PKD1 expression in ApoE knockout mice. Aging (Albany NY). 2019;11:10016-10030 pubmed 出版商
  13. Wu X, Chen S, Lu C. Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway. Int J Mol Med. 2019;: pubmed 出版商
  14. Kramer M, Markart P, Drakopanagiotakis F, Mamazhakypov A, Schaefer L, Didiasova M, et al. Pirfenidone inhibits motility of NSCLC cells by interfering with the urokinase system. Cell Signal. 2020;65:109432 pubmed 出版商
  15. Shan L, Liu W, Zhan Y. Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer. Aging (Albany NY). 2019;11:7780-7795 pubmed 出版商
  16. Yang L, Hong Q, Xu S, Kuang X, Di G, Liu G, et al. Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor‑κB signaling pathway. Mol Med Rep. 2019;20:4045-4258 pubmed 出版商
  17. He M, Shen P, Qiu C, Wang J. miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN. Aging (Albany NY). 2019;11:5744-5756 pubmed 出版商
  18. Yin Y, Zhang Q, Zhao Q, Ding G, Wei C, Chang L, et al. Tongxinluo Attenuates Myocardiac Fibrosis after Acute Myocardial Infarction in Rats via Inhibition of Endothelial-to-Mesenchymal Transition. Biomed Res Int. 2019;2019:6595437 pubmed 出版商
  19. Lee Y, Yeo I, Kim K, Han S, Hong J. Inhibition of Lung Tumor Development in ApoE Knockout Mice via Enhancement of TREM-1 Dependent NK Cell Cytotoxicity. Front Immunol. 2019;10:1379 pubmed 出版商
  20. Dosh R, Jordan Mahy N, Sammon C, Le Maitre C. Interleukin 1 is a key driver of inflammatory bowel disease-demonstration in a murine IL-1Ra knockout model. Oncotarget. 2019;10:3559-3575 pubmed 出版商
  21. Li Q, Youn J, Siu K, Murugesan P, Zhang Y, Cai H. Knockout of dihydrofolate reductase in mice induces hypertension and abdominal aortic aneurysm via mitochondrial dysfunction. Redox Biol. 2019;24:101185 pubmed 出版商
  22. Yi R, Zhang J, Sun P, Qian Y, Zhao X. Protective Effects of Kuding Tea (Ilex kudingcha C. J. Tseng) Polyphenols on UVB-Induced Skin Aging in SKH1 Hairless Mice. Molecules. 2019;24: pubmed 出版商
  23. Thompson P, Shah A, Ntranos V, Van Gool F, Atkinson M, Bhushan A. Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes. Cell Metab. 2019;29:1045-1060.e10 pubmed 出版商
  24. Guan H, Li N, Wang X, Shan X, Li Z, Lin Z. Role of Paip1 on angiogenesis and invasion in pancreatic cancer. Exp Cell Res. 2019;376:198-209 pubmed 出版商
  25. He S, Nian F, Chen W, Yin L, Auchoybur M, Tao Z, et al. I-κB kinase-ε knockout protects against angiotensin II induced aortic valve thickening in apolipoprotein E deficient mice. Biomed Pharmacother. 2019;109:1287-1295 pubmed 出版商
  26. Jin L, Lu J, Gao J. Silencing SUMO2 promotes protection against degradation and apoptosis of nucleus pulposus cells through p53 signaling pathway in intervertebral disc degeneration. Biosci Rep. 2018;38: pubmed 出版商
  27. Rempe R, Hartz A, Soldner E, Sokola B, Alluri S, Abner E, et al. Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy. J Neurosci. 2018;38:4301-4315 pubmed 出版商
  28. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  29. Yang L, Shen L, Gao P, Li G, He Y, Wang M, et al. Effect of AMPK signal pathway on pathogenesis of abdominal aortic aneurysms. Oncotarget. 2017;8:92827-92840 pubmed 出版商
  30. Lu J, Yang Y, Guo G, Liu Y, Zhang Z, Dong S, et al. IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway. Oncotarget. 2017;8:49502-49514 pubmed 出版商
  31. Zhai L, Liu M, Wang T, Zhang H, Li S, Guo Y. Picroside II protects the blood-brain barrier by inhibiting the oxidative signaling pathway in cerebral ischemia-reperfusion injury. PLoS ONE. 2017;12:e0174414 pubmed 出版商
  32. Hu X, Zhang Z, Liang Z, Xie D, Zhang T, Yu D, et al. Downregulation of feline sarcoma-related protein inhibits cell migration, invasion and epithelial-mesenchymal transition via the ERK/AP-1 pathway in bladder urothelial cell carcinoma. Oncol Lett. 2017;13:686-694 pubmed 出版商
  33. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed 出版商
  34. Li J, Liu Y, Yin Y. ARHGAP1 overexpression inhibits proliferation, migration and invasion of C-33A and SiHa cell lines. Onco Targets Ther. 2017;10:691-701 pubmed 出版商
  35. Mandl M, Zhang S, Ulrich M, Schmoeckel E, Mayr D, Vollmar A, et al. Inhibition of Cdk5 induces cell death of tumor-initiating cells. Br J Cancer. 2017;116:912-922 pubmed 出版商
  36. He Y, Wang X, Zhang J, Liu Z, Pan W, Shen Y, et al. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs. Arterioscler Thromb Vasc Biol. 2017;37:717-729 pubmed 出版商
  37. Dong Q, Fu L, Zhao Y, Tan S, Wang E. Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling. Oncotarget. 2017;8:17059-17069 pubmed 出版商
  38. Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, et al. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Biomed Pharmacother. 2017;88:421-429 pubmed 出版商
  39. Gan J, Wang F, Mu D, Qu Y, Luo R, Wang Q. RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy. Oncol Lett. 2016;12:4515-4523 pubmed 出版商
  40. Liu L, Guan H, Li Y, Ying Z, Wu J, Zhu X, et al. Astrocyte Elevated Gene 1 Interacts with Acetyltransferase p300 and c-Jun To Promote Tumor Aggressiveness. Mol Cell Biol. 2017;37: pubmed 出版商
  41. Zhang H, Zhang P, Gao Y, Li C, Wang H, Chen L, et al. Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs. Mol Med Rep. 2017;15:57-64 pubmed 出版商
  42. Burgy O, Bellaye P, Causse S, Beltramo G, Wettstein G, Boutanquoi P, et al. Pleural inhibition of the caspase-1/IL-1? pathway diminishes profibrotic lung toxicity of bleomycin. Respir Res. 2016;17:162 pubmed
  43. Liu Y, Wang T, Zhang R, Fu W, Wang X, Wang F, et al. Calorie restriction protects against experimental abdominal aortic aneurysms in mice. J Exp Med. 2016;213:2473-2488 pubmed
  44. Rai V, Dietz N, Dilisio M, Radwan M, Agrawal D. Vitamin D attenuates inflammation, fatty infiltration, and cartilage loss in the knee of hyperlipidemic microswine. Arthritis Res Ther. 2016;18:203 pubmed 出版商
  45. Xiao B, Chen D, Luo S, Hao W, Jing F, Liu T, et al. Extracellular translationally controlled tumor protein promotes colorectal cancer invasion and metastasis through Cdc42/JNK/ MMP9 signaling. Oncotarget. 2016;7:50057-50073 pubmed 出版商
  46. Tsai S, Huang P, Hsu Y, Peng Y, Lee C, Wang J, et al. Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases. Sci Rep. 2016;6:28612 pubmed 出版商
  47. Hou H, Chen L, Zha Z, Cai S, Tan M, Guo G, et al. Long form collapsin response mediator protein-1 promotes the migration and invasion of osteosarcoma cells. Oncol Lett. 2016;12:23-28 pubmed
  48. Lehner C, Gehwolf R, Ek J, Korntner S, Bauer H, Bauer H, et al. The blood-tendon barrier: identification and characterisation of a novel tissue barrier in tendon blood vessels. Eur Cell Mater. 2016;31:296-311 pubmed
  49. Zhou N, Zhu Y, Zhang P, Zhang Y, Zhou M, Wang T, et al. Imperatorin derivative OW1 inhibits the upregulation of TGF-? and MMP-2 in renovascular hypertension-induced cardiac remodeling. Exp Ther Med. 2016;11:1748-1754 pubmed
  50. Wang X, Wang N, Li H, Liu M, Cao F, Yu X, et al. Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine. Int J Mol Sci. 2016;17:577 pubmed 出版商
  51. Liang H, Zhang Q, Lu J, Yang G, Tian N, Wang X, et al. MSX2 Induces Trophoblast Invasion in Human Placenta. PLoS ONE. 2016;11:e0153656 pubmed 出版商
  52. Lim S, Yuzhalin A, Gordon Weeks A, Muschel R. Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells. Oncogene. 2016;35:5735-5745 pubmed 出版商
  53. Zeng W, Liu Q, Chen Z, Wu X, Zhong Y, Wu J. Silencing of hERG1 Gene Inhibits Proliferation and Invasion, and Induces Apoptosis in Human Osteosarcoma Cells by Targeting the NF-?B Pathway. J Cancer. 2016;7:746-57 pubmed 出版商
  54. Lai C, Tsai C, Kuo W, Ho T, Day C, Pai P, et al. Multi-Strain Probiotics Inhibit Cardiac Myopathies and Autophagy to Prevent Heart Injury in High-Fat Diet-Fed Rats. Int J Med Sci. 2016;13:277-85 pubmed 出版商
  55. Huang M, Liu T, Ma P, Mitteer R, Zhang Z, Kim H, et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J Clin Invest. 2016;126:1801-14 pubmed 出版商
  56. Serban A, Stanca L, Geicu O, Munteanu M, Dinischiotu A. RAGE and TGF-β1 Cross-Talk Regulate Extracellular Matrix Turnover and Cytokine Synthesis in AGEs Exposed Fibroblast Cells. PLoS ONE. 2016;11:e0152376 pubmed 出版商
  57. Shukla S, Sinha S, Khan S, Kumar S, Singh K, Mitra K, et al. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis. Sci Rep. 2016;6:21860 pubmed 出版商
  58. Alonso F, Domingos Pereira S, Le Gal L, Derré L, Meda P, Jichlinski P, et al. Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion. Oncotarget. 2016;7:14015-28 pubmed 出版商
  59. Liu T, Fang Z, Wang G, Shi M, Wang X, Jiang K, et al. Anti-tumor activity of the TRPM8 inhibitor BCTC in prostate cancer DU145 cells. Oncol Lett. 2016;11:182-188 pubmed
  60. Zhao L, Li S, Gan L, Li C, Qiu Z, Feng Y, et al. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression. J Cell Mol Med. 2016;20:842-54 pubmed 出版商
  61. Silva M, Matheus W, Garcia P, Stopiglia R, Billis A, Ferreira U, et al. Characterization of reactive stroma in prostate cancer: involvement of growth factors, metalloproteinase matrix, sexual hormones receptors and prostatic stem cells. Int Braz J Urol. 2015;41:849-58 pubmed 出版商
  62. Pei S, Yang X, Wang H, Zhang H, Zhou B, Zhang D, et al. Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2. BMC Cancer. 2015;15:965 pubmed 出版商
  63. Al Trad B, Ashankyty I, Alaraj M. Progesterone ameliorates diabetic nephropathy in streptozotocin-induced diabetic Rats. Diabetol Metab Syndr. 2015;7:97 pubmed 出版商
  64. Eiseler T, Wille C, Koehler C, Illing A, Seufferlein T. Protein Kinase D2 Assembles a Multiprotein Complex at the Trans-Golgi Network to Regulate Matrix Metalloproteinase Secretion. J Biol Chem. 2016;291:462-77 pubmed 出版商
  65. Zhang L, Zou W. Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway. Mol Med Rep. 2015;12:7869-76 pubmed 出版商
  66. Wardill H, Logan R, Bowen J, Van Sebille Y, Gibson R. Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer. Support Care Cancer. 2016;24:1779-88 pubmed 出版商
  67. Yan G, Wang Q, Hu S, Wang D, Qiao Y, Ma G, et al. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury. Int J Mol Med. 2015;36:1001-11 pubmed 出版商
  68. Chang L, Zhao D, Liu H, Wang Q, Zhang P, Li C, et al. Activation of sonic hedgehog signaling enhances cell migration and invasion by induction of matrix metalloproteinase-2 and -9 via the phosphoinositide-3 kinase/AKT signaling pathway in glioblastoma. Mol Med Rep. 2015;12:6702-10 pubmed 出版商
  69. Picot N, Guerrette R, Beauregard A, Jean S, Michaud P, Harquail J, et al. Mammaglobin 1 promotes breast cancer malignancy and confers sensitivity to anticancer drugs. Mol Carcinog. 2016;55:1150-62 pubmed 出版商
  70. Gan L, Zuo G, Wang T, Min J, Wang Y, Wang Y, et al. Expression of WTH3 in breast cancer tissue and the effects on the biological behavior of breast cancer cells. Exp Ther Med. 2015;10:154-158 pubmed
  71. Han Y, Lee J, Lee S. Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways. Mol Med Rep. 2015;12:3446-3452 pubmed 出版商
  72. Liu X, Wang J, Li S, Li L, Huang M, Zhang Y, et al. Histone deacetylase 3 expression correlates with vasculogenic mimicry through the phosphoinositide3-kinase / ERK-MMP-laminin5γ2 signaling pathway. Cancer Sci. 2015;106:857-66 pubmed 出版商
  73. Wang G, Liu G, Ye Y, Fu Y, Zhang X. The role of microRNA-1274a in the tumorigenesis of gastric cancer: accelerating cancer cell proliferation and migration via directly targeting FOXO4. Biochem Biophys Res Commun. 2015;459:629-35 pubmed 出版商
  74. Sun H, Zhang X, Zhao L, Zhen X, Huang S, Wang S, et al. Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor. J Cell Mol Med. 2015;19:836-49 pubmed 出版商
  75. Wiechmann A, Ceresa B, Howard E. Diurnal variation of tight junction integrity associates inversely with matrix metalloproteinase expression in Xenopus laevis corneal epithelium: implications for circadian regulation of homeostatic surface cell desquamation. PLoS ONE. 2014;9:e113810 pubmed 出版商
  76. Chavali P, Saini R, Zhai Q, Vizlin Hodzic D, Venkatabalasubramanian S, Hayashi A, et al. TLX activates MMP-2, promotes self-renewal of tumor spheres in neuroblastoma and correlates with poor patient survival. Cell Death Dis. 2014;5:e1502 pubmed 出版商
  77. Chen R, Xu B, Chen S, Chen S, Zhang T, Ren J, et al. Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells. World J Gastroenterol. 2014;20:14895-903 pubmed 出版商
  78. Lin C, Chen P, Hsu L, Kuo D, Chu S, Hsieh Y. Inhibition of the invasion and migration of renal carcinoma 786‑o‑si3 cells in vitro and in vivo by Koelreuteria formosana extract. Mol Med Rep. 2014;10:3334-42 pubmed 出版商
  79. Lee J, Chung L, Chen Y, Feng T, Juang H. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma. Cancer Lett. 2014;355:242-52 pubmed 出版商
  80. Long F, Cai X, Luo W, Chen L, Li K. Role of aldolase A in osteosarcoma progression and metastasis: in vitro and in vivo evidence. Oncol Rep. 2014;32:2031-7 pubmed 出版商
  81. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed 出版商
  82. Yang Y, Zhang J, Gong Y, Liu X, Bai Y, Xu W, et al. Increased expression of prostasin contributes to early-onset severe preeclampsia through inhibiting trophoblast invasion. J Perinatol. 2015;35:16-22 pubmed 出版商
  83. Calabro S, Maczurek A, Morgan A, Tu T, Wen V, Yee C, et al. Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis. PLoS ONE. 2014;9:e90571 pubmed 出版商
  84. Raimondi L, Amodio N, Di Martino M, Altomare E, Leotta M, Caracciolo D, et al. Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity. Oncotarget. 2014;5:3039-54 pubmed
  85. Chen R, Zhang F, Song L, Shu Y, Lin Y, Dong L, et al. Transcriptome profiling reveals that the SM22?-regulated molecular pathways contribute to vascular pathology. J Mol Cell Cardiol. 2014;72:263-72 pubmed 出版商
  86. Hughes B, Fan X, Cho W, Schulz R. MMP-2 is localized to the mitochondria-associated membrane of the heart. Am J Physiol Heart Circ Physiol. 2014;306:H764-70 pubmed 出版商
  87. Nie S, Zhou J, Bai F, Jiang B, Chen J, Zhou J. Role of endothelin A receptor in colon cancer metastasis: in vitro and in vivo evidence. Mol Carcinog. 2014;53 Suppl 1:E85-91 pubmed 出版商
  88. Seo J, Kim T, Leem Y, Lee K, Park S, Baek I, et al. SK-PC-B70M confers anti-oxidant activity and reduces Abeta levels in the brain of Tg2576 mice. Brain Res. 2009;1261:100-8 pubmed 出版商
  89. Morani A, Barros R, Imamov O, Hultenby K, Arner A, Warner M, et al. Lung dysfunction causes systemic hypoxia in estrogen receptor beta knockout (ERbeta-/-) mice. Proc Natl Acad Sci U S A. 2006;103:7165-9 pubmed